Amgen Ltd

Information

Name

Amgen Ltd

Type

Company

Roles

Supplier

Company Size

Large

Company Number

Incorporation Date

Website

http://www.amgen.com

Address

Cambridge

United Kingdom

Suppliers

Unlock the full supplier list, free!

Sign up to unlock the full list of suppliers associated with Amgen Ltd
Sign up free

Contracts awarded to Amgen Ltd

The contracts that Amgen Ltd have been awarded to supply. Click on the contract to view more detailed information and view the full details about the contract won.

Award

Published 8 months ago

NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024

Project Title: NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024 Offer reference number: CM/PHR/22/5678 CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B. Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A. Period of framework: 1 March 2024 to 31 August 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B). Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months

£580,156,000 Bids close: 1 year ago
Award

Published 9 months ago

NP47923c Eculizumab

Supply of eculizumab to NHS Scotland.

£10,508,400
Award

Published 9 months ago

NP47923a Adalimumab

Supply of adalimumab to NHS Scotland.

£44,618,492
Award

Published 9 months ago

NHS National Framework Agreement for the supply of Eculizumab - 1 Feb 2024

Project Title: NHS National Framework Agreement for the supply of Eculizumab - 1 Feb 2024 Offer reference number: CM/PHR/22/5693 Period of framework: 1 February 2024 to 30 April 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

£32,653,000 Bids close: 11 months ago
Award

Published 9 months ago

NHS National Framework for Natalizumab-February 2024

Project Title: NHS National Framework Agreement for the supply of Eculizumab - 1 Feb 2024<br/>Offer reference number: CM/PHR/22/5693<br/>Period of framework: 1 February 2024 to 30 April 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.

£3

Contacts

[email protected]

+44 1223436406

Statistics (1 Year)

Contracts Won

Total Won

£68,943,470

Average Win

£22,981,157

Amgen Ltd

Information

Name

Type

Roles

Company Size

Company Number

Incorporation Date

Website

Address

Suppliers

Contracts awarded to Amgen Ltd

NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024

NP47923c Eculizumab

NP47923a Adalimumab

NHS National Framework Agreement for the supply of Eculizumab - 1 Feb 2024

NHS National Framework for Natalizumab-February 2024

Contacts

Statistics (1 Year)

Contracts Won

Total Won

Average Win